Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder

Contraception

Volumn 99, Issue 1, 2019, Pages 36-41

  Kotha, Anupama ^a   Chen, Beatrice A ^a,b   Lewis, Lauren ^c   Dunn, Shannon ^b   Himes, Katherine P ^a,b   Krans, Elizabeth E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Long acting reversible contraception; Opioid use disorder; Postpartum contraception; Pregnancy

Indexed keywords

OPIATE;

ADULT; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DISEASE ASSOCIATION; DSM-5; FEMALE; FEMALE STERILIZATION; HEALTH CARE ACCESS; HEALTH CARE UTILIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONG-ACTING REVERSIBLE CONTRACEPTION; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL HISTORY; MEDICAL RECORD; MEDICAL RECORD REVIEW; OPIATE ADDICTION; PARITY; PATIENT COUNSELING; PREGNANCY; PREGNANT WOMAN; PRENATAL PERIOD; PRIVATE PRACTICE; PUERPERIUM; RETROSPECTIVE STUDY; RISK FACTOR; BEHAVIOR; OPIATE SUBSTITUTION TREATMENT; PATIENT ATTITUDE; PRENATAL CARE; PSYCHOLOGY; YOUNG ADULT;

ADULT; FEMALE; HUMANS; INTENTION; LONG-ACTING REVERSIBLE CONTRACEPTION; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PATIENT ACCEPTANCE OF HEALTH CARE; POSTPARTUM PERIOD; PREGNANCY; PRENATAL CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85054518064     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2018.08.008     Document Type: Article

References (25)

1. Heil, S.H., Jones, H.E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., et al. Unintended pregnancy in opioid-abusing women. J Subst Abus Treat 40 (2011), 199–202.
2. Finer, L.B., Zolna, M.R., Declines in unintended pregnancy in the United States, 2008-2011. N Engl J Med 374 (2016), 843–852.
3. Black, K.I., Stephens, C., Haber, P.S., Lintzeris, N., Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol 52 (2012), 146–150.
4. Terplan, M., Hand, D.J., Hutchinson, M., Salisbury-Afshar, E., Heil, S.H., Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review. Prev Med 80 (2015), 23–31.
5. Krans, E.E., Cochran, G., Bogen, D.L., Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations. Clin Obstet Gynecol 58 (2015), 370–379.
6. Krans, E.E., Kim, J.Y., James, A.E. III, Kelley, D.K., Jarlenski, M., Postpartum contraceptive use and interpregnancy interval among women with opioid use disorder. Drug Alcohol Depend 185 (2018), 207–213.
7. Thiel de Bocanegra, H., Braughton, M., Bradsberry, M., Howell, M., Logan, J., Schwarz, E.B., Racial and ethnic disparities in postpartum care and contraception in California's Medicaid program. Am J Obstet Gynecol 217 (2017), 47.e1–47.e7.
8. Krans, E.E., Zickmund, S.L., Rustgi, V.K., Park, S.Y., Dunn, S.L., Schwarz, E.B., Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: a retrospective cohort study. Subst Abus 37 (2016), 88–95.
9. Krans, E.E., Bogen, D., Richardson, G., Park, S.Y., Dunn, S.L., Day, N., Factors associated with buprenorphine versus methadone use in pregnancy. Subst Abus 37 (2016), 550–557.
10. Harrell, F.E., Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. 2001, Springer, New York.
11. American College of Obstetricians and Gynecologists. Practice Bulletin No. 186: Long-Acting Reversible Contraception: Implants and Intrauterine Devices. Obstet Gynecol, 130, 2017, e251-e69.
12. Matusiewicz, A.K., Melbostad, H.S., Heil, S.H., Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder. Contraception 96 (2017), 365–369.
13. Ogburn, J.A., Espey, E., Stonehocker, J., Barriers to intrauterine device insertion in postpartum women. Contraception 72 (2005), 426–429.
14. Engin-Ustun, Y., Ustun, Y., Cetin, F., Meydanli, M.M., Kafkasli, A., Sezgin, B., Effect of postpartum counseling on postpartum contraceptive use. Arch Gynecol Obstet 275 (2007), 429–432.
15. Chen, B.A., Reeves, M.F., Hayes, J.L., Hohmann, H.L., Perriera, L.K., Creinin, M.D., Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol 116 (2010), 1079–1087.
16. Optimizing postpartum care. ACOG Committee Opinion No. 736. American College of Obstetrics and Gynecologists. Obstet Gynecol, 131, 2018, e140–e150.
17. Baldwin, M.K., Hart, K.D., Rodriquez, M.I., Predictors for follow-up among postpartum patients enrolled in a clinical trial. Contraception, 2018 [Epub ahead of print].
18. Krans, E.E., Tong, S.T., Terplan, M., Postpartum care for women with substance use disorders. Wright, T.E., (eds.) Opioid use disorders in pregnancy: Management guidelines for improving outcomes, 2018, Cambridge University Press, Cambridge, UK, 113–126.
19. American College of Obstetrics and Gynecologists, Committee on Obstetric Practice, Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstet Gynecol 128 (2016), e32–e37.
20. Connolly, A., Thorp, J., Pahel, L., Effects of pregnancy and childbirth on postpartum sexual function: a longitudinal prospective study. Int Urogynecol J Pelvic Floor Dysfunct 16 (2005), 263–267.
21. Hofler, L.G., Cordes, S., Cwiak, C.A., Goedken, P., Jamieson, D.J., Kottke, M., Implementing immediate postpartum long-acting reversible contraception programs. Obstet Gynecol 129 (2017), 3–9.
22. Medicaid Reimbursement for Postpartum LARC by State. Accessed at https://www.acog.org/About-ACOG/ACOG-Departments/Long-Acting-Reversible-Contraception/Immediate-Postpartum-LARC-Medicaid-Reimbursement on June 29th, 2018.
23. Uhm, S., Pope, R., Schmidt, A., Bazella, C., Perriera, L., Home or office etonogestrel implant insertion after pregnancy: a randomized trial. Contraception 94:5 (2016), 567–571.
24. Schauberger, C.W., Newbury, E.J., Colburn, J.M., Al-Hamadani, M., Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting. Am J Obstet Gynecol, 211, 2014.
25. Krans, E.E., Bobby, S., England, M., Gedekoh, R.H., Chang, J.C., Maguire, B., et al. The pregnancy recovery center: a women-centered treatment program for pregnant and postpartum women with opioid use disorder. Addict Behav, 24, 2018 [Epub ahead of print].